Cargando…

Some metabolic issues should not be neglected when using citrate for continuous renal replacement therapy!

Detalles Bibliográficos
Autores principales:	Jacobs, Rita, Honore, Patrick M, Spapen, Herbert D
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4320486/ https://www.ncbi.nlm.nih.gov/pubmed/25738824 http://dx.doi.org/10.1186/s13054-015-0766-3

Ejemplares similares

Optimizing citrate dose for regional anticoagulation in continuous renal replacement therapy: measuring citrate concentrations instead of ionized calcium?
por: Honore, Patrick M., et al.
Publicado: (2015)

Intertwining extracorporeal membrane oxygenation and continuous renal replacement therapy: sense or nonsense?
por: Jacobs, Rita, et al.
Publicado: (2015)

Chloride content of solutions used for regional citrate anticoagulation might be responsible for blunting correction of metabolic acidosis during continuous veno-venous hemofiltration
por: Jacobs, Rita, et al.
Publicado: (2016)

Correction to: Chloride content of solutions used for regional citrate anticoagulation might be responsible for blunting correction of metabolic acidosis during continuous venovenous hemofiltration
por: Jacobs, Rita, et al.
Publicado: (2020)

What a Clinician Should Know About a Renal Replacement Membrane?
por: Honore, Patrick M., et al.
Publicado: (2018)

Eliminating endotoxin by polymyxin B hemoperfusion and/or continuous renal replacement therapy: should the focus be on timing, dosing, and type of renal epuration?
por: Honore, Patrick M., et al.
Publicado: (2019)

‘Biomarking’ infection during continuous renal replacement therapy: still relevant?
por: Honore, Patrick M, et al.
Publicado: (2015)

Biomarker validity in the critically ill: all must face the (continuous) renal replacement challenge!
por: Honore, Patrick M., et al.
Publicado: (2015)

Higher colistin dose during continuous renal replacement therapy: look before leaping!
por: Honore, Patrick M., et al.
Publicado: (2015)

Continuous renal replacement therapy for safe and adequate voriconazole intravenous treatment: enough reason to be confident?
por: Honore, Patrick M, et al.
Publicado: (2015)

Is neutrophil gelatinase-associated lipocalin unaffected by convective continuous renal replacement therapy? Definitely … maybe
por: Honore, Patrick M., et al.
Publicado: (2015)

Metabolic and coagulation effects of citrate: down to the last detail!
por: Honore, Patrick M., et al.
Publicado: (2015)

Citrate: How to Get Started and What, When, and How to Monitor?
por: Honore, Patrick M., et al.
Publicado: (2018)

Cefepime-induced neurotoxicity in critically ill patients undergoing continuous renal replacement therapy: beware of dose reduction!
por: Honore, Patrick M., et al.
Publicado: (2015)

Prognosis of extremely severe lactic acidosis in metformin-treated patients with septic shock: continuous (?) renal replacement therapy in the spotlight!
por: Honore, Patrick M., et al.
Publicado: (2016)

Presepsin and sepsis-induced acute kidney injury treated with continuous renal replacement therapy: will another promising biomarker bite the dust?
por: Honore, Patrick M., et al.
Publicado: (2015)

Neutrophil gelatinase-associated lipocalin elimination by renal replacement therapy: minding the membrane!
por: Honore, Patrick M., et al.
Publicado: (2016)

A Double Catheter Approach for Extracorporeal CO(2) Removal Integrated Within a Continuous Renal Replacement Circuit
por: Bels, David De, et al.
Publicado: (2018)

Vitamin C Dosing During Continuous Renal Replacement Therapy: The Last Word is Not Said!
por: Honore, Patrick M., et al.
Publicado: (2019)

Dosing adjuvant vitamin C in critically ill patients undergoing continuous renal replacement therapy: We are not there yet!
por: Honore, Patrick M., et al.
Publicado: (2019)

Unapparent systemic effects of regional anticoagulation with citrate in continuous renal replacement therapy: a narrative review
por: Boer, Willem, et al.
Publicado: (2023)

Renal and neurological side effects of colistin in critically ill patients
por: Spapen, Herbert, et al.
Publicado: (2011)

Citrate anticoagulation for continuous renal replacement therapy in small children
por: Soltysiak, Jolanta, et al.
Publicado: (2013)

Citrate for continuous renal replacement therapy: safer, better and cheaper
por: Oudemans-van Straaten, Heleen M
Publicado: (2014)

Regional citrate anticoagulation for continuous renal replacement therapy in newborns
por: Huang, Haixia, et al.
Publicado: (2023)

Retrospective evaluation of possible renal toxicity associated with continuous infusion of vancomycin in critically ill patients
por: Spapen, Herbert D, et al.
Publicado: (2011)

The blind spot in high-dose tigecycline pharmacokinetics in critically ill patients: membrane adsorption during continuous extracorporeal treatment
por: Honore, Patrick M, et al.
Publicado: (2015)

Clinical review: Anticoagulation for continuous renal replacement therapy - heparin or citrate?
por: Oudemans-van Straaten, Heleen M, et al.
Publicado: (2011)

Normal saline as resuscitation fluid in critically ill patients: not dead yet!
por: Honore, Patrick M., et al.
Publicado: (2016)

Optimal timing of renal replacement therapy initiation in acute kidney injury: the elephant felt by the blindmen?
por: Shiao, Chih-Chung, et al.
Publicado: (2017)

Renal tubular acidosis with hyperchloremic acidosis: harmless with a sting?
por: Honore, Patrick M., et al.
Publicado: (2015)

Regional Citrate Anticoagulation in Continuous Renal Replacement Therapy: Is Metabolic Fear the Enemy of Logic? A Systematic Review and Meta-Analysis of Randomised Controlled Trials
por: Jacobs, Rita, et al.
Publicado: (2023)

Citrate versus heparin anticoagulation in continuous renal replacement therapy in small children
por: Raymakers-Janssen, Paulien A. M. A., et al.
Publicado: (2017)

Dosing vitamin C in critically ill patients with special attention to renal replacement therapy: a narrative review
por: Honore, Patrick M., et al.
Publicado: (2020)

Stability of citrate and calcium dosing in citrate renal replacement therapy
por: Sadaat, F, et al.
Publicado: (2015)

Adjuvant vitamin C in cardiac arrest patients undergoing renal replacement therapy: an appeal for a higher high-dose
por: Honore, Patrick M., et al.
Publicado: (2018)

Citrate Anticoagulation for Continuous Renal Replacement Therapy in Critically Ill Patients: Success and Limits
por: Mariano, Filippo, et al.
Publicado: (2011)

Bench-to-bedside review: Citrate for continuous renal replacement therapy, from science to practice
por: Oudemans-van Straaten, Heleen M, et al.
Publicado: (2012)

Regional citrate anticoagulation for continuous renal replacement therapy in pediatric patients with liver failure
por: Rodriguez, Keila, et al.
Publicado: (2017)

Anidulafungin dosing during CRRT: do not underestimate adsorption!
por: Honore, Patrick M, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_gdu7u4gl5ash2j8uu00pcb9sms